Neuroactive steroids, WIN-compounds and cholesterol share a common binding site on muscarinic acetylcholine receptors
Language English Country Great Britain, England Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
34324870
DOI
10.1016/j.bcp.2021.114699
PII: S0006-2952(21)00312-9
Knihovny.cz E-resources
- Keywords
- Allosteric modulation, Cholesterol, Muscarinic receptors, Neuroactive steroids,
- MeSH
- Allosteric Regulation drug effects physiology MeSH
- Androstanes metabolism pharmacology MeSH
- Androstenes metabolism pharmacology MeSH
- Benzimidazoles metabolism pharmacology MeSH
- CHO Cells MeSH
- Cholesterol metabolism MeSH
- Cricetulus MeSH
- Cricetinae MeSH
- Humans MeSH
- Neuromuscular Nondepolarizing Agents metabolism pharmacology MeSH
- Neurosteroids metabolism MeSH
- Receptors, Muscarinic metabolism MeSH
- Gallamine Triethiodide metabolism pharmacology MeSH
- Binding Sites drug effects physiology MeSH
- Vecuronium Bromide analogs & derivatives metabolism pharmacology MeSH
- Animals MeSH
- Check Tag
- Cricetinae MeSH
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Androstanes MeSH
- Androstenes MeSH
- Benzimidazoles MeSH
- Cholesterol MeSH
- Neuromuscular Nondepolarizing Agents MeSH
- Neurosteroids MeSH
- rapacuronium MeSH Browser
- Receptors, Muscarinic MeSH
- Gallamine Triethiodide MeSH
- Vecuronium Bromide MeSH
- WIN 51708 MeSH Browser
- WIN 62577 MeSH Browser
Endogenous neurosteroids and their synthetic analogues-neuroactive steroids-have been found to bind to muscarinic acetylcholine receptors and allosterically modulate acetylcholine binding and function. Using radioligand binding experiments we investigated their binding mode. We show that neuroactive steroids bind to two binding sites on muscarinic receptors. Their affinity for the high-affinity binding site is about 100 nM. Their affinity for the low-affinity binding site is about 10 µM. The high-affinity binding occurs at the same site as binding of steroid-based WIN-compounds that is different from the common allosteric binding site for alcuronium or gallamine that is located between the second and third extracellular loop of the receptor. This binding site is also different from the allosteric binding site for the structurally related aminosteroid-based myorelaxants pancuronium and rapacuronium. Membrane cholesterol competes with neurosteroids/neuroactive steroids binding to both high- and low-affinity binding site, indicating that both sites are oriented towards the cell membrane..
Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences Prague Czech Republic
Institute of Physiology Czech Academy of Sciences Prague Czech Republic
References provided by Crossref.org
Muscarinic Receptors in Cardioprotection and Vascular Tone Regulation
Allosteric Modulation of Muscarinic Receptors by Cholesterol, Neurosteroids and Neuroactive Steroids